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Fragile X Syndrome is the most common form of heritable cognitive disability. It 
is caused by a genetic mutation that leads to a lack of protein from the FMR1 gene. This 
protein (FMRP) is used to regulate the translation of many other proteins, thereby leading 
to a wide range of effects. Because the origin of this disease is based on the lack of a 
single protein, an animal model with construct validity can be used to investigate the 
potential effects leading to the symptoms of the disease. 
 Many studies have investigated the synaptic plasticity differences of CA1 
pyramidal neurons between a mouse model of fragile X syndrome (KO) and a wild type 
mouse (WT). This study investigates the differences in firing properties of a CA1 
pyramidal neuron between the KO and WT. Specifically, contributions of two ion 
channels are investigated: the Ca2+ and voltage activated potassium channel (BK) and the 
potassium channel (M) inhibited by the muscarinic acetylcholine receptor. 
 This study finds some differences that warrant further investigation, 
including differences in spike timing, spike width and the initial rate of rise of an action 
 vii 
potential. However, several areas of investigation yield subtle or confounding results, 
which may indicate that the CA1 pyramidal neurons affected by the lack of FMRP may 
make up more than one population. 
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Chapter 1: Introduction 
In humans, cognitive impairments can be caused by several factors, both 
environmental and genetic. The most common genetic cause of these impairments is 
Fragile X syndrome (FXS). FXS patients also display other characteristics such as 
childhood seizures, hyperactivity, hypersensitivity to stimuli, delayed language 
development, and limited eye contact. It is also the leading genetic cause of autism. This 
disease is caused by a lack of the fragile X protein (FMRP). A mutation upstream of the 
gene (FMR1), consisting of an excessive number (>200) of CGG repeats, causes a hyper-
methylation of the region and blocks translation (Bell et al., 1991).  
FMRP has several biological functions. It is most known for binding to 
mRNA/ribosomal complexes and suppressing translation. In neurons, it has also been 
implicated in mRNA transport and in activity-dependent, local translation. Interestingly, 
FMRP is also known to regulate it’s own translation. In the disease, the lack of FMRP 
protein can lead to an overabundance of protein, differentially localized mRNA, and the 
disruption of signaling pathways that relied on activity dependent regulation of FMRP 
and its associated mRNA. 
Because the source mutation is known and affects only one gene, a transgenic 
mouse has been created that lacks a functional FMR1 gene (KO) (Anon, 1994).  The 
mouse has been used in comparison with a wild type mouse (WT) to investigate 
morphological, physiological and behavioral consequences of a lack of FMRP, as well as 
in evaluating the ability of potential drug therapies to reverse some of the differences.  
In both humans and the mouse model of the disease there are striking 
morphological differences in the spines of pyramidal neurons (Galvez and Greenough, 
2005; Grossman et al., 2006). In addition, studies of synaptic plasticity in the mouse 
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model have shown an increase in group I mGluR dependent LTD in the KO (Huber, 
2002; Bear et al., 2004). The focus of research is expanding to include investigations of 
ion channels regulating the intrinsic properties of neurons including KV4.2 (Gross et al., 
2011; Lee et al., 2011), HCN (Brager et al., 2012), KV3.1 (Strumbos et al., 2010), and the 
sodium-activated potassium channel Slack (Brown et al., 2010). 
 
Figure 1.1: Various currents involved in the active properties of a neuron. A, currents 
that affect the wave form and after polarizations of an action potential. B, 
currents that affect the timing and after polarizations of multiple action 
potentials. Adapted from (Storm, 1990) 
However, the output mechanism, via action potential firing, has not yet been 
investigated for this disease model. A binding study has shown that the mRNA of several 
ion channels involved in modulating the action potential waveform are possible targets of 
FMRP including: NaV1.2, NaV1.6, ID channel KV1.2, delayed rectifier KV2.1, IA channel 
KV4.2, IM channels KV7.2 and KV7.3, and the voltage and calcium activated potassium 
channel BK (Darnell et al., 2011). All of these channels can play a role in modulating the 
shape and timing of action potentials including threshold, width, height, and firing rate 
(Fig. 1.1) (Storm, 1990; Bean, 2007). I have investigated differences in action potential 
waveforms and in trains of action potentials between FMR1 knockout mice as compared 
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to wild type mice. I have pursued the involvement of BK channels and M-channels in 
these differences. I also have some proof of concept biochemical work needed to 




Chapter 2: General Methods 
ANIMALS 
Male mice with the background C57BL/6 from 2 to 3.5 months were used. Some 
mice carried a mutation where the FMR1 gene would not be expressed. The genotype of 
these animals is FMR1-/y and is referred to as FMR1 knockout (KO). The mice without 
the mutation are referred to as wild type (WT). Treatment of animals and experiments 
were within guidelines of the University of Texas at Austin IACUC. 
SLICE PREPARATION 
Mice were given a lethal injection of ketamine and xylazine. Once deeply 
anesthetized, mice were intracardially perfused with ice cold ACSF containing (in mM): 
210 sucrose, 2.5 KCl, 1.2 NaH2PO4, 25 NaHCO3, 0.5 CaCl2, 7.0 MgCl2, and 7.0 dextrose 
bubbled with 95% O2 / 5% CO2. The brain was removed, bisected along the midline, and 
blocked for medial hippocampus. The brain was then mounted and 300 µm slices were 
obtained using a microtome. Slices were transferred to a holding chamber warmed to 
35°C filled with ACSF containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 
NaHCO3, 2 CaCl2, 2 MgCl2, and 12.5 dextrose bubbled with 95% O2 / 5% CO2. Slices 
were maintained at 35°C for 30 minutes and then kept at room temperature until used. 
ELECTROPHYSIOLOGY 
Slices were transferred to a recording chamber perfused with 31-34°C ACSF 
similar to that in the holding chamber with the exception of 3 µM KCl. Borosilicate glass 
patch pipettes (3-6 MΩ) were filled with internal solution containing (in mM): 120 K-
gluconate, 20 KCl, 11 HEPES, 4 NaCl, 4 MgATP, 0.3 Na-GTP, 7 K2-phosphocreatine 
and 0.1 % neurobiotin adjusted to pH 7.3 unless otherwise noted.  
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Whole cell current clamp recordings were obtained using a Multiclamp 700B. 
Series resistance was continually monitored, and recordings where it exceeded 30 MΩ 
were discarded. Synaptic blockers were used in all experiments. Unless otherwise noted, 
the blocker concentrations used were (in µM): 20 DNQX, 50 AP5, and 2 gabazine. 
 
Figure 2.1:  Spiking protocols. A, single spike protocols. B, action potential train 
protocols. 
For most experiments, the membrane voltage (Vm) was adjusted to -65 mV by 
constant current injection. Input resistance (RN) and rebound measurements were 
collected from a family of hyperpolarizing and depolarizing current steps. The maximum 
and steady state RN were calculated as the slope of the current-voltage (IV) plots. 
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Maximum voltage values were measured as an average of 10 milliseconds (ms) around 
the peak of the voltage change (usually early in the trace). Steady state voltage values 
were measured as an average of a 50 ms window before the end of the step. The rebound 
slope is obtained from the steady state voltage plotted against the rebound amplitude 
from baseline.  
 
Figure 2.2: Measurements of single action potentials. 
When taking measurements for single action potentials, three protocols that varied 
the length of the current injection were used: 2 ms, 20 ms, and 100 ms (Fig 2.1A). For 
each protocol, the amount of current injected was adjusted to elicit a single action 
potential timed to be close to the middle of the current injection. Threshold is measured 
as the point where the first derivative equals 20 mV/ms. Action potential height is 
measured from threshold to peak. Half width is the width of the action potential at ½ the 
height. Third width is the width of the action potential at 1/3 the height (Fig. 2.2). The 
maximum rate of change is the peak of the first derivative. The initial rate of change was 
the first derivative at two timepoints: 50 µs and 100 µs after threshold.  
Two protocols were used to analyze trains of action potentials (Fig 2.1B). One 
protocol was a 50 ms current injection adjusted to yield 5 spikes (5sp). The final protocol 
was a family of depolarizing current injections 500 ms in length to invoke increasing 
numbers of action potentials (FI). Additional protocols will be specifically described in 
the chapters below. 
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DATA ACQUISITION AND ANALYSIS 
In general recordings were sampled over 2x the filter rate. Recordings were 
digitized by an ITC-18 interface and captured by Axograph software. Wave analysis was 
performed by Axograph software.  
STATISTICAL ANALYSIS 
All data were expressed at mean ± SEM. Significance was determined by 
student’s t-test when comparing 2 conditions. For more than 2 conditions a 2 factor 
ANOVA was used with Tukey’s post hoc test. p < 0.05 was considered significant. 
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Chapter 3: Passive and active properties of CA1 pyramidal neurons in 
FMR1 knockout mice 
INTRODUCTION 
Passive properties of CA1 pyramidal cells were compared between FMR1 
knockout mice and wild type mice to verify previous data reporting similarities in these 
properties at the soma (Brager et al., 2012).  Several experiments were performed to 
determine what differences may exist in the firing properties of these cells between the 
WT and KO.  
METHODS 
Sampling and filtering rates used for these experiments were either 10 kHz 
sampling, 3 kHz filtering; or 50 kHz sampling, 10 kHz filtering. 
RESULTS 
There were no significant differences in the resting membrane potential, rebound 
or maximum and steady state input resistances between the WT and KO (Fig. 3.1).  When 
comparing the properties of single spikes, no significant differences in threshold or spike 
peak were found (Fig 3.2. A, B). However, some significant differences were found 
related to the rate of rise of single spikes. The maximum of the first derivative of the 2 ms 
spike was significantly larger (i.e. faster) in the WT when compared to the KO (Fig. 3.2 
C, p=0.045). The initial rate of rise, occurring 100 µs after threshold, was significantly 
larger in the WT for all three spiking protocols: 2 ms, 20 ms and 100 ms (Fig 3.2 D, 




Figure 3.1: Comparison of passive properties between WT and KO.  
 
Next, trains of action potentials were investigated. When comparing firing rate, 
the WT and KO were fairly similar; however, for smaller current injections the WT 
displayed a faster firing rate while for larger current injections the KO had a faster firing 
rate. This reached significance for current injections of 380 and 400 pA (Fig 3.3 p=0.044, 
0.025). A subset of traces from the FI protocol where 16 spikes occurred was analyzed. 
The inter-spike interval (ISI) was calculated and the WT and KO values were compared. 
Early in the spike train, the KO had larger inter-spike intervals; but as the train continued, 
the WT showed more spike frequency adaptation resulting in ISIs that were smaller in the 
KO.  The first, second and third intervals were significantly larger in the KO (Fig. 3.4 A 
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and B, p=0.006, 0.038 and 0.003). The last three intervals in the spike train were 
significantly smaller in the KO (Fig. 3.4 A and B, p=0.0001, 0.026 and 0.015). 
 
 
Figure 3.2: Comparison of spiking properties between WT and KO.  * p<0.05. 
The difference in spike amplitude between the first spike and last spike in the 
train were analyzed. The data is plotted based on the total number of spikes in the train 
(Fig. 3.5). As the number of spikes in a train increased (due to an increasing amount of 
current injected), the amplitude of the last spike was reduced more in the WT than in the 
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KO (7: p= 0.001, 10: p=0.044, 14: p=0.023, 16: p=0.029, 17: p=0.028, 18: p=0.031, 19: 
p=0.035, 20: p=0.005, 21: p=0.023, 22: p=0.009, 24: p=0.015, 25: p=0.015). 
 
Figure 3.3: Firing rate plotted against current injection. * p<0.05. 
 
Figure 3.4: Comparison of spiking timing in a train containing 16 spikes. A, summary 
data for WT and KO. B, sample traces. ** p<0.01, * p<0.05. 
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Figure 3.5: Comparison of spike amplitude attenuation in a train over an increasing 
number of spikes in a train. A, summary data for WT and KO. B, sample 
traces. ** p<0.01, * p<0.05. 
DISCUSSION 
The differences seen in the maximum slope of an action potential could be due to 
differences in various conductances. However, the fact that the differences are even more 
pronounced at very early time points of the action potential, 50 and 100 µs, indicates an 
involvement of the Na current.  Somewhat surprising is that there was no significant 
difference in threshold even though there is a difference in initial slope.  
Spike timing is influenced by several potassium conductances including the Ca2+ 
and voltage activated conductance BK, the small Ca2+ activated conductance SK, and a 
potassium conductance, M, which is activated at low voltages. Differences in BK and M 
currents are discussed in chapters 4 and 5 respectively. 
The spike amplitude attenuation differences could be due to several possible 
conductances. These include inactivation of Na channels or activation of K channels such 
as the A-type channel.  
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Chapter 4: Contribution of BK channels in firing properties of CA1 
pyramidal neurons in FMR1 knockout mice 
INTRODUCTION 
One of the significant differences found between wild type and FMR1 knockout 
mice is spike frequency adaptation, both early and late in a train. There are several ion 
channels that are known to have an effect on spike timing, two of which are Ca2+-
activated potassium channels (Lancaster and Adams, 1986; Lancaster and Nicoll, 1987; 
Gu et al., 2007). One of these channels is known as SK and has no voltage component to 
its activation. The other channel has a combined voltage and Ca2+ activation and is known 
as BK.  SK has a relatively small conductance may contribute to the medium and slow 
hyperpolarizations after an action potential (AHP) for certain neuron types. BK has a 
large potassium conductance and is responsible for the fast AHP (Storm, 1987; Poolos 
and Johnston, 1999). Even though both of these channels are involved in spike timing, 
only mRNA of the alpha subunit of BK has been shown to be a candidate for regulation 
by FMRP (Darnell et al., 2011). Although there may be secondary effects of FMRP on 
SK, only BK was investigated. 
Tetramers of the alpha subunit form the channel pore and contain the Ca2+ and 
voltage sensitive domains. There are 4 BK beta subunits (β1 – β4); however, only β2 and 
β4 are expressed in the brain. The β2 subunit confers inactivation and increases Ca2+ 
sensitivity. The β4 subunit modulates the Ca2+ sensitivity and causes the channel to be 
insensitive to block by iberiotoxin. On the other hand, BK channels are sensitive to block 
by paxilline regardless of associated subunit.  
Paxilline was used during whole cell current clamp recordings to block BK 
channels. Data from WT and KO cells was compared both before and after application of 
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paxilline to investigate differential effects. Differential effects could indicate that FMRP 
is involved in the expression or function of the channel in CA1 pyramidal neurons. 
METHODS 
Electrophysiology 
After experimental protocols are run initially, 10 µM paxilline, a BK channel 
blocker, is added to the external ACSF for the remainder of the experiment. Input 
resistance is monitored for 10 minutes to give the paxilline time to take effect. Then 
experimental protocols are executed a second time. 
Sampling and filtering rates used for these experiments were either 10 kHz 
sampling, 3 kHz filtering; or 50 kHz sampling, 10 kHz filtering. 
Statistical Analysis 
To determine significant differences when comparing data including genotype 
and drug application, a two factor ANOVA was used. The drug application factor was 
treated as a repeated measure. Significant differences were determined using a post hoc 
Tukey’s test. 
RESULTS 
For all three single spike protocols (2 ms, 20ms, and 100ms), 10 µM paxilline had 
the expected effect of increasing both the halfwidth and the width measured at 1/3 height 
(Fig 4.1). All spikes were significantly wider after paxilline application. Furthermore, the 
results indicated that the 1/3 width measurement was significantly different before 
application of paxilline for both the 2 ms protocol (p=0.039) and the 20 ms protocol 
(p=0.019). In both cases, the width of the action potentials is narrower in the KO.  
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Figure 4.1:  Comparison of width of single spikes between WT and KO both before and 
after application of BK channel blocker paxilline. A, summary data for the 
halfwidth measurement for the 2ms, 20 ms and 100 ms protocols. B, 
summary data for the 1/3 width measurement. The KO is significantly 
narrower for the 2 ms and the 20 ms protocols.  C, D, E, representative 
traces for the 2 ms, 20 ms and 100 ms protocols respectively.  
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Figure 4.2: Comparison of width of spikes in a train between WT and KO both before 
and after paxilline application. A, halfwidth measurements for four spikes. 
B, 1/3 width measurements for four spikes. *: p<0.05 for WT vs. KO before 
paxilline application; #: p<0.05 for WT vs. KO after paxilline application; x: 
p <0.05 before vs. after paxilline application for genotype (applies to WT 
and KO separately). 
Spike width was also analyzed for a train of spikes using the 5 spike protocol (Fig 
4.2) although only the first 4 spikes were analyzed because the fifth spike could have 
occurred during the off step of the current injection. For the halfwidth measurement, the 
first spike was significantly different after paxilline application for both WT (p=0.038) 
and KO (p=0.002). Alternatively, the second spike was significantly different between 
the WT and KO mice both before (p=0.0194) and after paxilline application (p=0.033). 
Significant differences in the thirdwidth  (Fig 4.2B) measurements were similar to that of 
halfwidth (first spike: WT p=0.013, KO p=0.001; second spike: before paxilline 
p=0.0188; after paxilline p=0.037) with the addition of a significant difference in the first 





Figure 4.3:  Traces from the 5 spike protocol. A. Representative traces from the 5 spike 
protocol for WT, WT after paxilline, KO and KO after paxilline. B. 
Overlays of the first spike and overlays of the second spike with significant 




Figure 4.4: Larger datasets from WT and KO mice were compared with no drug. A, 
Data set 1 is from experiments where paxilline was subsequently applied. 
Data set 2 is from experiments where no post paxilline measurements were 
taken. B, data from experiments from Chapter 3 are compared with the 
merged data set from this chapter (labeled –BK). All significant differences 
in data sets (* p < 0.05, ** p < 0.01) and in variance (#) are shown. 
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Because significant differences were seen in the width measurements of single 
spikes before drug application, other data sets that had width measurements without drug 
application were added to the analysis. One of these data sets came from experiments 
where paxilline was applied but no post paxilline measurements were obtained (Fig 
4.4A). With this expanded data set, no significant differences were found. However, the 
variance of the KO and WT data sets were different for each of the 3 protocols. 
Additionally, these combined data sets (WT-BK and KO-BK) were compared with data 
sets from experiments shown in Chapter 3 where no drug application was involved (WT-
nd and KO-nd). The WT-BK measurements were significantly different from KO-nd 
measurements for all three protocols: 2 ms (p=0.003), 20 ms, (p=0.004) and 100 ms 
(p=0.002). Surprisingly, the WT-BK measurements were also significantly different from 
the WT-nd measurements for all three protocols (2 ms: p=0.014, 20 ms p=0.012, and 100 
ms: p=0.023). Furthermore, when comparing the variance of these data sets, the KO-BK 
variance was different from each of the other three data sets, WT-BK, WT-nd, and KO-
nd, for each of the three protocols. When the two WT data sets are merged and the two 
KO data sets are merged, the variances are different only for the 20 ms and 100 ms 
protocols. 
DISCUSSION 
The results from these paxilline experiments are not conclusive. Analysis of data 
before paxilline was applied shows significant differences in the width at 1/3 height of 
single action potentials elicited with a 2 ms or 20 ms current injection. However, when 
this data is combined with other experiments where post-paxilline measurements were 
not taken, no significant differences are seen. Instead more variability of the data is seen 
for the KO. This could indicate that there is more than one population of pyramidal cells 
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that have differing properties in the KO due to the lack of FMRP. Another possibility is 
that paxilline is not completely washed out of the chamber between experiments and 
residual paxilline has contaminated some of the data. 
However, there are potential conclusions that can be drawn from the width of 
spikes in a train (Fig: 4.2). Only the first spike has a different width before and after 
paxilline application for both the WT and KO (Fig 4.3A). This indicates that BK has its 
greatest effect on these spikes. It is possible that the KO has more BK given that the 
width at 1/3 height of the first spike is narrower in the KO before paxilline. After 
paxilline application has removed the BK contribution to the spike train, the width is no 
longer significantly different for the first spike. The significant differences in the width of 
the second spike are also interesting but probably not related to BK. The widths are 
significantly different between WT and KO before paxilline application, but also after 
paxilline application when there should be no contribution from BK (Fig. 4.3B). This 
indicates that while BK differences may be affecting the initial spike, there is likely at 




Chapter 5: Contribution of M channels in CA1 pyramidal neurons in 
FMR1 knockout mice 
INTRODUCTION 
In addition to Ca2+-activated potassium channels, other potassium channels, such 
as the M channel, contribute to the after hyperpolarization, and therefore can effect spike 
frequency adaptation (Madison and Nicoll, 1984; Storm, 1989). Furthermore, mRNA for 
two of the subunits that form the M-channel, KV7.2 and KV7.3, are candidates for 
regulation by FMRP (Darnell et al., 2011). The M-channel activation range is controlled 
by several factors, including subunit composition, but tends to be slightly more 
depolarized than rest. For this reason most experiments were done holding the cell at -70 
mV and again at -60 mV. Although at negative potentials, Ih can contribute to an after-
hyperpolarization, initially no blocker was used because previous work (Brager et al., 
2012) has shown no difference in Ih at the soma.  
METHODS 
Two sets of experiments were performed that differed in their internal solutions, 
ion channel blockers, and the concentration of M-channel blocker XE991. The first set of 
experiments used the standard internal and blockers as specified in the general methods 
section and 10 µM XE991 was used to block IM. EPSPs were simulated using 2 
exponential equations. Two additional protocols were used: 1) a 500 ms current injection 
adjusted to yield 8 spikes and 2) 5 1 ms current injections just large enough to invoke an 
action potential delivered at 100 Hz.  
A second set of experiments were performed with an internal and blockers that 
were more similar to work done by (Shah et al., 2011) in an attempt to replicate her data 
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from rat in the mouse. For these experiments (in µM), K-gluconate was replaced with 
120 KMeSO3, gabazine was replaced with 10 bicuculline and 1 CGP55845, and 3 XE991 
was used instead of 10. In addition, 10 µM ZD7288 (ZD) was used to remove any AHP 
due to Ih. For these experiments, the EPSPs were simulated using an α function (Fig 5.1). 
The data from these experiments are shown with a gray background in the figures below. 
The medium after-hyperpolarization (mAHP) was obtained by offsetting the trace 
so baseline is 0, and then finding the most negative value after the spike(s) once the trace 
has hyperpolarized below 0, within a 100 ms window after the end of the current 
injection. Analysis using the integral of this area below baseline yielded similar results 
(data not shown).  
 
Figure 5.1:  The timeline for the XE991 infusion and the protocols used for the 
simulated EPSPs and measuring the mAHPs. 
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EPSP summation was calculated as the amplitude of the fifth EPSP divided by the 
amplitude of the first EPSP. 
Data was sampled at 50 kHz and filtered at 20 kHz. 
Student’s t-test with repeated measures was used to determine significant 
differences before and after drug application. 
 
RESULTS 
Resting membrane potential was significantly different before and after 
application of XE991 (Fig. 5.2A) for the WT (p=0.0014) and KO (p=0.03). In addition 
the steady state input resistance (Fig 5.2B) was significantly different before and after 
drug application for the WT at -70 mV (p=0.012) and for the KO at both -60 mV 
(p=0.016) and -70 mV (p=0.011).  
 
Figure 5.2: Resting membrane potential and input resistance for WT and KO before and 
after 10 µM XE991 (* p<0.05). 
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Figure 5.3: Interspike interval for 8 spikes in WT and KO before and after 10 µM 
XE991. A, ISI at -60 mV holding potential and sample traces (# indicates 
difference in variance of the measurments after XE991). B, ISI at -70 mV 
holding potential and sample traces (*: p<0.05 between KO after XE991 and 
both WT measurements). 
A 500 ms current injection, adjusted to elicit 8 spikes, was used to measure inter-
spike intervals (ISI). At a holding potential of -60 mV (Fig 5.3A), there were no 
significant differences between WT and KO before and after drug application. However, 
the data points for the second and third intervals after drug application had different 
variances. At -70 mV (Fig 5.3B), there were some significant differences. For the first 
interval, the KO after XE991 was significantly different from the WT both before 
(p=0.0053) and after XE991 (p=0.019). Similarly for the 6th interval, the KO after XE991 
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differed significantly from the WT both before (p=0.0054) and after XE991 (p=0.026). 
Although only significant for the -70 mV holding potential, at both holding potentials the 
ISI in the KO after drug was smaller than the WT. In both the WT and KO after drug, the 
cells had a propensity to fire in bursts of 2 spikes. Interestingly, the KO tended to fire two 
spikes initially while the WT fired one spike initially before transitioning to a 2 spike 
bursting mode. 
 
Figure 5.4: Medium AHP measurements from a burst of 5 spikes at 100 Hz for WT and 
KO before and after 10 µM XE991. There were no significant differences. 
To evaluate the medium AHP (mAHP) directly, a protocol consisting of a burst of 
5 spikes delivered at 100 Hz was used. This protocol was executed from holding 
potentials of both -60 and -70 mV. Although the data are not significantly different 
among the conditions (genotype or drug), the trend was for the mAHP to get larger (i.e. 
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more hyperpolarized) contrary to expectations (Fig. 5.4). To further evaluate the 
effectiveness of XE991, internal solutions, synaptic blockers and XE991 concentration 
were changed to be more similar to that in existing published work, and ZD7288 was 
used to remove any AHP due to Ih. This condition is referred to as “modified internal” in 
the text and with “+ZD” and on a gray background in graphs. 
 
 
Figure 5.5:  Medium AHP for both sets of conditions (normal and modified internal). 
Example traces shown. 
Using the 50 ms protocol, where the current is adjusted to elicit 5 spikes, the 
mAHP was obtained as the offset from baseline. At -70 mV, the new conditions, which 
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included ZD, removed most occurrences of a medium AHP (Fig 5.5). At -60 mV, while 
no significant differences occurred, the trend of the averaged data for both conditions 
differed between WT and KO.  The WT had a reduction in mAHP whereas the KO had 
an increase in mAHP.  
 
  
Figure 5.6: EPSP amplitude for both sets of conditions (normal and modified internal) 
with sample traces.  
Simulated EPSPs were also used to evaluate the M current in the KO and WT. For 
single EPSPs, the trend for both WT and KO was an increase in amplitude after 
application of XE991 (Fig 5.6). Only two conditions showed significant differences in a 
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repeated measures t-test: the WT with normal internal at -60 mV (p=0.045) and the KO 
with modified internal at -70 mV (p=0.0107). For the summation protocols, there were no 
significant differences between WT and KO before or after drug application within either 
normal or modified internal (Fig 5.7, 5.8). 
 
 
Figure 5.7: EPSP summation ratio at 20 Hz for both sets of conditions (normal and 
modified internal) with sample traces.  
DISCUSSION 
Applying the M-channel blocker, XE991, had a similar effect for WT and KO in 
that it led to a 2-spike burst. This is in agreement with previous work in the rat (Yue and 
Yaari, 2004). There was a difference in the bursting pattern however, where the KO 
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tended to start with a doublet, while the WT tended to start with a single spike before 
transitioning into doublets. It is not clear what causes the continuation of the doublets; 
however, they were common in both WT and KO after drug application.  
 
 
Figure 5.8: EPSP summation ratio at 40 Hz for both sets of conditions (normal and 
modified internal) with sample traces.  
On the other hand, two protocols that typically yield differences in rat after 
application of XE991 did not result in differences in either WT or KO mice.  A measure 
of mAHP resulted in differing trends between the WT and KO, but none of these 
differences were significant (Fig 5.5). Experiments looking at the height of a single 
simulated EPSP and the summation of 5 EPSPs were performed to analyze the changes in 
both the WT and KO before and after XE991 (Fig 5.6). Previous work in rat showed that 
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applying XE991 leads to a significant increase in summation of EPSPs delivered at 20 Hz 
and 40 Hz when the neuron is held at -60 mV (Shah et al., 2011). These experiments in 
mice show no significant differences in summation. In addition, only two of the eight 
EPSP amplitude measurements were significantly different before and after XE991. 
Differences in resting potential and input resistance in both WT and KO after XE991 
application indicate that the drug did have an effect on the neurons (Fig 5.1). One 
possible explanation of why XE991 did not produce all the expected results is that M 
channels might not located peri-somatically in the mouse as they are in the rat. Therefore 
changes due to the drug in the mouse would not be seen as readily when measured at the 
soma. Another possibility is that the neither of the internal solutions used are effective at 
showing IM effects. One recommendation would be to use KMeSO4 instead of either the 
K-gluconate or KMeSO3 that was used here. Thirdly, there might be a difference in M 
channel subunit composition between the rat and mouse that yields these differing results. 
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Chapter 7: Discussion 
In general, the differences in the firing properties between a FMR1 KO mouse 
and a WT mouse are fairly subtle. They are most easily seen when looking at spike 
frequency adaptation and spike amplitude attenuation in a train of spikes.  
The investigation of differential contributions of BK could be enhanced by a 
larger data set and by the addition of biochemistry measures for αBk, Bk β4 and Bk β2. 
In addition, experiments using iberiotoxin could be used to investigate differences in αBk 
or Bk β2. 
The investigation of M current contributions yielded some confusing results based 
on the unexpeceted outcomes to some of the measurements after infusion of XE991. It 
would be worth investigating differences between a WT mouse and rat, and establishing a 
solid baseline of expected results in mice before continuing work with the FMR1 KO 
mouse. This investigation could also be enhanced with some biochemistry assays for 
Kv7.2 and Kv7.3. 
When interpreting the inter-spike interval (ISI) data it is useful to consider 
possible effects of BK and M channels together. The BK data suggests that it is most 
influential after the first spike in a train. Experiments from the application of XE991, 
which cause the removal of M current, yield a bursting pattern that is most variable for 
the first ISI. The M current that is present in the BK experiments could be a 
compensatory mechanism that may be occluding spike timing differences due to BK. If 
the KO truly does have more BK than the WT, then the KO could have a doublet because 
of the quick repolarization and recovery of Na channels from inactivation. In the non-
drug scenario presumably the M current is maintaining a more hyperpolarized membrane 
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potential, which spreads out the timing between the first 2 spikes. It would be interesting 
to see the effect of paxilline and XE991 together in the KO and WT mice. 
Finally, the data indicating a decrease in the initial rate of rise in the KO are 
compelling. However, to date it has been very difficult to get consistent results among the 
techniques used to study INa at the axon initial segment. As techniques are improved and 
new methods become available, the impact on the AIS of the missing FMR1 protein 
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